140 related articles for article (PubMed ID: 28195442)
1. Genetic modulation of fetal hemoglobin in hydroxyurea-treated sickle cell anemia.
Aleluia MM; Santiago RP; da Guarda CC; Fonseca TC; Neves FI; Quinto RS; Figueiredo CV; Yahouédéhou SC; Oliveira RM; Ferreira JR; Cerqueira BA; Barbosa CG; Milton JN; Steinberg MH; de Souza Gonçalves M
Am J Hematol; 2017 May; 92(5):E70-E72. PubMed ID: 28195442
[No Abstract] [Full Text] [Related]
2. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
Italia K; Jain D; Gattani S; Jijina F; Nadkarni A; Sawant P; Nair S; Mohanty D; Ghosh K; Colah R
Blood Cells Mol Dis; 2009; 42(1):25-31. PubMed ID: 18954999
[TBL] [Abstract][Full Text] [Related]
3. Candidate sequence variants and fetal hemoglobin in children with sickle cell disease treated with hydroxyurea.
Green NS; Ender KL; Pashankar F; Driscoll C; Giardina PJ; Mullen CA; Clark LN; Manwani D; Crotty J; Kisselev S; Neville KA; Hoppe C; Barral S
PLoS One; 2013; 8(2):e55709. PubMed ID: 23409025
[TBL] [Abstract][Full Text] [Related]
4. Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5' olfactory receptor gene cluster.
Solovieff N; Milton JN; Hartley SW; Sherva R; Sebastiani P; Dworkis DA; Klings ES; Farrer LA; Garrett ME; Ashley-Koch A; Telen MJ; Fucharoen S; Ha SY; Li CK; Chui DH; Baldwin CT; Steinberg MH
Blood; 2010 Mar; 115(9):1815-22. PubMed ID: 20018918
[TBL] [Abstract][Full Text] [Related]
5. Modulation of fetal hemoglobin in sickle cell anemia.
Steinberg MH
Hemoglobin; 2001 May; 25(2):195-211. PubMed ID: 11480781
[TBL] [Abstract][Full Text] [Related]
6. [From Hemoglobin SS to SF: interest of hydroxyurea in the management of sickle cell disease in two Congolese children and review of the literature].
Nkashama GM; Wakamb GK; Mulangu AM; Nkashama GM; Kupa BK; Numbi OL
Pan Afr Med J; 2015; 21():124. PubMed ID: 26327961
[TBL] [Abstract][Full Text] [Related]
7. Response to hydroxyurea among Kuwaiti patients with sickle cell disease and elevated baseline HbF levels.
Adekile A; Menzel S; Gupta R; Al-Sharida S; Farag A; Haider M; Akbulut N; Mustafa N; Thein SL
Am J Hematol; 2015 Jul; 90(7):E138-9. PubMed ID: 25851995
[No Abstract] [Full Text] [Related]
8. Fetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyurea.
Ma Q; Wyszynski DF; Farrell JJ; Kutlar A; Farrer LA; Baldwin CT; Steinberg MH
Pharmacogenomics J; 2007 Dec; 7(6):386-94. PubMed ID: 17299377
[TBL] [Abstract][Full Text] [Related]
9. Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes.
Sheehan VA; Luo Z; Flanagan JM; Howard TA; Thompson BW; Wang WC; Kutlar A; Ware RE;
Am J Hematol; 2013 Jul; 88(7):571-6. PubMed ID: 23606168
[TBL] [Abstract][Full Text] [Related]
10. Concordant fetal hemoglobin response to hydroxyurea in siblings with sickle cell disease.
Steinberg MH; Voskaridou E; Kutlar A; Loukopoulos D; Koshy M; Ballas SK; Castro O; Barton F
Am J Hematol; 2003 Feb; 72(2):121-6. PubMed ID: 12555216
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyurea: specific therapy for sickle cell anemia?
Kaufman RE
Blood; 1992 May; 79(10):2503-6. PubMed ID: 1375102
[No Abstract] [Full Text] [Related]
12. Effects of hydroxyurea in a population of Brazilian patients with sickle cell anemia.
Vicari P; Barretto de Mello A; Figueiredo MS
Am J Hematol; 2005 Mar; 78(3):243-4. PubMed ID: 15726590
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyurea increases fetal hemoglobin production in sickle cell anemia.
Platt OS; Orkin SH; Dover G; Beardsley GP; Miller B; Nathan DG
Trans Assoc Am Physicians; 1984; 97():268-74. PubMed ID: 6085528
[No Abstract] [Full Text] [Related]
14. Hydroxyurea, sickle cell disease and renal transplantation.
Allen A; Scoble J; Snowden S; Hambley H; Bellingham A
Nephron; 1997; 75(1):106-7. PubMed ID: 9031282
[No Abstract] [Full Text] [Related]
15. Hydroxyurea therapy for diverse pediatric populations with sickle cell disease.
Rogers ZR
Semin Hematol; 1997 Jul; 34(3 Suppl 3):42-7. PubMed ID: 9317200
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic manipulation of fetal hemoglobin. Update on clinical trials with hydroxyurea.
Dover GJ
Ann N Y Acad Sci; 1990; 612():184-90. PubMed ID: 1705407
[No Abstract] [Full Text] [Related]
17. Sickle cell disease severity: an introduction.
Pace BS; Goodman SR
Exp Biol Med (Maywood); 2016 Apr; 241(7):677-8. PubMed ID: 27190296
[No Abstract] [Full Text] [Related]
18. Long-term use of hydroxyurea for sickle cell anemia.
Hagar W
JAMA; 2003 Aug; 290(6):753; author reply 754. PubMed ID: 12915424
[No Abstract] [Full Text] [Related]
19. Hydroxyurea and sickle cell disease: a chance for every patient.
Weiner DL; Brugnara C
JAMA; 2003 Apr; 289(13):1692-4. PubMed ID: 12672739
[No Abstract] [Full Text] [Related]
20. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
Rodgers GP; Dover GJ; Uyesaka N; Noguchi CT; Schechter AN; Nienhuis AW
N Engl J Med; 1993 Jan; 328(2):73-80. PubMed ID: 7677965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]